Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 6 Ovarian Neoplasms 4 Neoplasms 3 Endometrial Neoplasms 3 Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Colorectal Neoplasms 1 Bulbo-Spinal Atrophy, X-Linked 1 Biliary Tract Neoplasms 1 Advanced Breast Cancer 1 Adenocarcinoma of Lung 1

Interventions

pembrolizumab 156 Gemcitabine 139 Capecitabine 121 Paclitaxel 119 Fluorouracil 116 Oxaliplatin 110 Bevacizumab 104 Nivolumab 97 Leucovorin 97 Docetaxel 93 Cisplatin 90 Irinotecan 88 Carboplatin 85 Radiosurgery 83 Cyclophosphamide 71 Cetuximab 70 Magnetic Resonance Spectroscopy 68 Trastuzumab 56 Specimen Handling 56 Biopsy 56 Radiotherapy 55 Ipilimumab 52 Everolimus 48 Pemetrexed 46 Drug Therapy 45 Albumin-Bound Paclitaxel 44 130-nm albumin-bound paclitaxel 43 Doxorubicin 41 Fulvestrant 38 aldesleukin 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasm Metastasis × AZD5305 × Clear all

NCT06713369 2026-03-04

AZD5305

AstraZeneca

Phase 1 Recruiting

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡